Search for: "Gilead Sciences Limited" Results 41 - 60 of 84
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Nov 2018, 2:47 am
Speakers include Jocelyn Man (Gilead), Joanna Peak (Boult Wade Tennant), Rob Whittock (Hardwicke Chambers), Alexandra Pygall (Stephenson Harwood), and Mark Abthorpe (Kilburn & Strode). [read post]
4 Oct 2015, 11:35 am by Patrick A. Malone
Hiltzik recalled how earlier this year, another member of the Big Pharma club, Gilead Sciences, limited its patient-assistance program for Sovaldi and Harvoni, drugs that treat hepatitis C for more money than most people make in a year. [read post]
31 Jul 2016, 9:30 pm by Dori Molozanov
Gilead Sciences spent $11 billion to acquire the rights to Sovaldi in 2011, and put it on the market in 2013. [read post]
9 May 2017, 4:42 am
Arnold J. reiterated his view (expressed previously in Teva UK Ltd v Gilead Sciences Inc [2017] EWHC 13 (Pat)) that the test in Lilly remains unclear. [read post]
18 Apr 2020, 4:03 am by SHG
Brainard is the head of antiviral clinical research at Gilead Sciences, the Bay Area biotech giant whose drug portfolio includes the antiviral medicine remdesivir. [read post]
15 Sep 2022, 2:13 am by Neil Wilkof
Notably, Article 1360 had never been applied in practice since 2006, the year of enactment of Part IV of the Civil Code covering IP rights.Interestingly, several months before this amendment, the Government issued an order allowing a Russian legal entity, “Pharmasyntez”, to use Remdesivir, an antiviral medication used for treatment of Covid-19, without authorization of the patent owner, Gilead Sciences, Inc. [read post]
7 Dec 2014, 3:29 pm
‘It’s Idenix Pharmaceutical, Inc v Gilead Sciences, Inc & Others [2014] EWHC 3916 (Pat) (01 December 2014)’, Darren might answer. [read post]
3 Feb 2019, 7:44 am by Lisa Ouellette
" This basic science is crucial, and expensive. [read post]
26 Jun 2015, 12:30 am
 Actually, Mr Justice Arnold had himself moved away from the idea already - he distinguished his decision in the later case of Idenix Pharmaceutical, Inc v Gilead Sciences, Inc (reported by IPKat here) in which he declined to construe a claim narrowly on the basis of the prosecution history.This did not however have any effect on the outcome - Floyd LJ otherwise endorsed Arnold J's application of the Protocol questions to likewise find that there was no direct… [read post]
30 Jul 2020, 3:39 pm by Lisa Larrimore Ouellette
We have written about the FDA’s emergency use authorization for remdesivir, which Gilead will soon be selling for $3,120 per course. [read post]
8 Dec 2023, 7:58 am by Timothy Bonis
Gilead, 2019), but some experts believe Amgen expanded the requirement. [read post]
19 Oct 2011, 3:30 am by Marie Louise
(IPBiz) US: Patent protection for the BRCA1 gene and genetic diagnostic methods in the USA: AMP v USPTO (JIPLP) US: Marking with an unenforceable patent does not create intent to deceive: Hollander v Hospira (Chicago Intellectual Property Law Blog) US: Regenerative Sciences lawsuit update and FDA’s attempt to broaden the definition of “interstate commerce”: USA v Regenerative Sciences (FDA Law Blog)   Products Embeda (Morphine, Naltrexone) – US: Pfizer,… [read post]
5 Jan 2015, 5:08 am
This, in chronological order and excluding regular omnibus posts, is what we brought you last week:* The SKYVolt's the limit, even if you forget the wind, sun and water ...Jeremy writes about Stone Electrical Ltd v British Sky Broadcasting Group plc, a decision of the Irish Patents Office that considered whether a ‘SKYVolt Generators of power by Wind, Sun and Water’ sign for goods and services related to renewable energy could be registered in the face of BSkyB’s… [read post]